Nerve Growth Factor

Randomized double-blind placebo controlled trial

250 patients

Symptomatic diabetic polyneuropathy with abnormalities of NCS and QST

Age range 18-60 years

NGF given SQ three times per week for 6 months

Small improvement in sensory symptoms and QST

Previous slide

Next slide

Back to first slide

View graphic version